MedPath

A clinical trial on effectiveness of complimentary Ayurvedic treatment to increase cancer free life in healthy women carrying BRCA 1/2 gene, which is highly responsible for cancer of breast and ovary.

Phase 2
Registration Number
CTRI/2018/01/011644
Lead Sponsor
Dr S P Sardeshmukh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Genetically predisposed healthy women with BRCA1/2 mutation carriers within 6 months to 1 year of diagnosis not suffering from any type of cancer.

Exclusion Criteria

Healthy men who are BRCA 1/2 mutation carriers.

Healthy carriers of BRCA 1/2 mutation who are already taking other Ayurvedic treatments.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath